Each month, the CDI team rounds up some of the latest #GIcommunity research, news, and trends and how they impact functional GI diagnostics and treatment of patients worldwide.
This month, we are featuring several resources, articles, and research from the 2021 ACG Annual Scientific Meeting, which took place in Las Vegas and virtually from October 22nd to 27th. Registered participants can access on-demand and recorded sessions via the ACG 2021 Conference Platform through March 2022.
Highlights from ACG 2021
For the first time in two years, GI physicians from the U.S. and worldwide gathered in person for the ACG Annual Scientific Meeting, with hybrid virtual options also available to those unable to travel to Las Vegas. This year’s conference delivered the latest clinical information on timely topics in gastroenterology and hepatology, including abstracts, commentary, and perspectives from some of the biggest names in the industry who are working to advance digestive health and improve patient care:
Author Insights from Newsworthy Abstracts:
ACG’s Public Relations Committee annually identifies and features scientific findings that are “innovative, newsworthy for the lay reader, relevant to those who suffer from common GI problems, and which represent a significant advancement in the diagnosis and treatment of GI diseases.
The End of the Beginning: Megatrends in Gastroenterology
In the J. Edward Berk Distinguished Lecture, The End of the Beginning: Megatrends in Gastroenterology, William Chey, MD, explained where he believes gastroenterology is heading and how digital health, integrated care, and artificial intelligence will enable personalized healthcare in the coming year. HCPLive summarized Dr. Chey’s discussion on the importance of a multidisciplinary integrated care approach to treating irritable bowel syndrome (IBS).
The Impact of Diet on Patients with IBS
Rawan Algaras, MD, from Indiana University School of Medicine, spoke to HCPLive about the various ways in which diet can influence a patient’s gastrointestinal health.
Key Research Presented on Functional GI Disorders:
The following are several key posters and oral presentations from ACG 2021 focused on functional gastrointestinal disorders, including two that summarize GI disease prevalence and burden and one that could have a long-term impact on the use of AI for diagnostics:
- Abdominal Bloating in the U.S.: Results of a National Survey of 88,969 Americans Examining Prevalence, Burden of Illness, and Healthcare Seeking
- Examining the Impact of the COVID-19 Pandemic on the Prevalence of Rome IV Functional Gastrointestinal Disorders
- Validation of Novel Mobile App Using Artificial Intelligence to Capture and Objectively Characterize Stool Images in a Clinical Trial
Exclusive GI Community Webinar: 2021 Year in Review + 2022 Outlook Functional GI Trends
Join CDI and our expert GI panel for a GI Community Exclusive Webinar on November 10th as we break down timely themes and new research presented at ACG 2021 and provide perspective on what’s to come in 2022.
Industry Coverage of ACG 2021
With presentations and research papers ranging from the impact of COVID-19 to clinical best practices and the latest technological advances, industry media publications reported daily on the latest news, research, and topics presented at ACG 2021:
